OCA Ventures completes Amplified Sciences' $1.8M seed round
Summary
CEO Diana Caldwell and Rajesh Ummadisetti of Amplified Sciences prepare for an experiment of the companys diagnostics assay. Diana Caldwell, CEO and president of Amplified Sciences, said the funding will enable validation of the company’s lead assay to detect pancreatic cancer and bring it closer to commercial launch. We believe Amplified Sciences complements our portfolio as it strives to detect pancreatic cancer sooner and help patients begin treatments earlier." "The national reach of investors and size of this seed round is significant as highlighted in the 2020 Indiana Life Sciences Capital Report published by BioCrossroads. The company has operations in West Lafayette, Indiana, leverages technology licensed from Purdue University, and has developed a platform that scales to point of care.